159 related articles for article (PubMed ID: 38672622)
21. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.
Yang Z; Zhao N; Cui J; Wu H; Xiong J; Peng T
Cell Oncol (Dordr); 2020 Feb; 43(1):123-136. PubMed ID: 31713003
[TBL] [Abstract][Full Text] [Related]
22. AMPK-related kinase 5 (ARK5) enhances gemcitabine resistance in pancreatic carcinoma by inducing epithelial-mesenchymal transition.
Wang X; Song Z; Chen F; Yang X; Wu B; Xie S; Zheng X; Cai Y; Chen W; Zhong Z
Am J Transl Res; 2018; 10(12):4095-4106. PubMed ID: 30662653
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of ZNF488 supports pancreatic cancer cell proliferation and tumorigenesis through inhibition of ferroptosis via regulating SCD1-mediated unsaturated fatty acid metabolism.
Xiao Q; Lan Z; Zhang S; Ren H; Wang S; Wang P; Feng L; Li D; Wang C; Bai X; Zhang J
Biol Direct; 2023 Nov; 18(1):77. PubMed ID: 37986084
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells.
Hong P; Wu M; Wei X; Xu X; Wu P; Gan L; Wu R; Jin J; Zhang K; Li D; Chen M; Wong W; Liu W; Zheng X
Bioorg Chem; 2024 Jan; 142():106937. PubMed ID: 37913583
[TBL] [Abstract][Full Text] [Related]
25. Arsenic trioxide inhibits Skp2 expression to increase chemosensitivity to gemcitabine in pancreatic cancer cells.
Gao J; Wang G; Wu J; Zuo Y; Zhang J; Chen J
Am J Transl Res; 2019; 11(2):991-997. PubMed ID: 30899398
[TBL] [Abstract][Full Text] [Related]
26. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy.
Song J; Xu J; Guo J; Shang Y; Wang J; Wang T
Acta Histochem; 2021 Sep; 123(6):151769. PubMed ID: 34416437
[TBL] [Abstract][Full Text] [Related]
27. CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR-485-5p and to Target PAK1.
Lu Y; Zhou S; Cheng G; Ruan Y; Tian Y; Lv K; Han S; Zhou X
J Oncol; 2022; 2022():1911592. PubMed ID: 36059806
[TBL] [Abstract][Full Text] [Related]
28. Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer.
Fan K; Fan Z; Cheng H; Huang Q; Yang C; Jin K; Luo G; Yu X; Liu C
Cancer Med; 2019 Oct; 8(13):5903-5915. PubMed ID: 31426130
[TBL] [Abstract][Full Text] [Related]
29. The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe.
Drápela S; Khirsariya P; van Weerden WM; Fedr R; Suchánková T; Búzová D; Červený J; Hampl A; Puhr M; Watson WR; Culig Z; Krejčí L; Paruch K; Souček K
Mol Oncol; 2020 Oct; 14(10):2487-2503. PubMed ID: 32579780
[TBL] [Abstract][Full Text] [Related]
30. Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling.
Cui J; Guo Y; Wu H; Xiong J; Peng T
Mol Med; 2021 Apr; 27(1):38. PubMed ID: 33849427
[TBL] [Abstract][Full Text] [Related]
31. PARP14 promotes the proliferation and gemcitabine chemoresistance of pancreatic cancer cells through activation of NF-κB pathway.
Yao N; Chen Q; Shi W; Tang L; Fu Y
Mol Carcinog; 2019 Jul; 58(7):1291-1302. PubMed ID: 30968979
[TBL] [Abstract][Full Text] [Related]
32. N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway.
Lin C; Wang Y; Dong Y; Lai S; Wang L; Weng S; Zhang X
Biol Direct; 2022 Nov; 17(1):33. PubMed ID: 36397058
[TBL] [Abstract][Full Text] [Related]
33. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro.
Liu DL; Bu H; Li H; Chen H; Guo HC; Wang ZH; Tong HF; Ni ZL; Liu HB; Lin SZ
Int J Oncol; 2012 Apr; 40(4):1049-57. PubMed ID: 22159556
[TBL] [Abstract][Full Text] [Related]
34. Identification of chemoresistance-related mRNAs based on gemcitabine-resistant pancreatic cancer cell lines.
Zhou J; Zhang L; Zheng H; Ge W; Huang Y; Yan Y; Zhou X; Zhu W; Kong Y; Ding Y; Wang W
Cancer Med; 2020 Feb; 9(3):1115-1130. PubMed ID: 31823522
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of microRNA-messenger RNA regulatory network in gemcitabine-resistant bladder cancer cells.
Zhang S; Chang YY; Gong YW; Gao YJ; Guo Q; Wang YH; Zhao YL; Wang ZP
J Cell Biochem; 2019 Apr; 120(4):6347-6360. PubMed ID: 30304549
[TBL] [Abstract][Full Text] [Related]
36. Synergistic antitumor efficacy of gemcitabine and cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via Sp1-SAT1-polyamine metabolism pathway.
Wei W; Lu Y; Hu Q; Yin J; Wang Y; Zhang H; Zhao Q; Liu L
Cell Oncol (Dordr); 2024 Feb; 47(1):321-341. PubMed ID: 37684512
[TBL] [Abstract][Full Text] [Related]
37. CXCL12 secreted by pancreatic stellate cells accelerates gemcitabine resistance of pancreatic cancer by enhancing glycolytic reprogramming.
Lu X; Wu Y; Cao R; Yu X; Gong J
Anim Cells Syst (Seoul); 2022; 26(4):148-157. PubMed ID: 36046033
[TBL] [Abstract][Full Text] [Related]
38. circACTR2 attenuates gemcitabine chemoresiatance in pancreatic cancer through PTEN mediated PI3K/AKT signaling pathway.
Xu C; Ye Q; Ye C; Liu S
Biol Direct; 2023 Mar; 18(1):14. PubMed ID: 36991449
[TBL] [Abstract][Full Text] [Related]
39. The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway.
Li Q; He J; Li S; Tian C; Yang J; Yuan H; Lu Y; Fagone P; Nicoletti F; Xiang M
Clin Immunol; 2023 Mar; 248():109217. PubMed ID: 36581220
[TBL] [Abstract][Full Text] [Related]
40. Co-delivery of gemcitabine and Triapine by calcium carbonate nanoparticles against chemoresistant pancreatic cancer.
Zhao Y; Zheng Y; Zhu Y; Ding K; Zhou M; Liu T
Int J Pharm; 2023 Apr; 636():122844. PubMed ID: 36925025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]